Normal view MARC view ISBD view

Booth, A D

Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. [electronic resource] - Circulation Apr 2004 - 1718-23 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1524-4539

Standard No.: 10.1161/01.CIR.0000124720.18538.DD doi

Subjects--Topical Terms:
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Antibodies, Antineutrophil Cytoplasmic--analysis
Antibodies, Monoclonal--administration & dosage
Autoimmune Diseases--blood
C-Reactive Protein--analysis
Churg-Strauss Syndrome--blood
Cohort Studies
Cyclophosphamide--administration & dosage
Drug Therapy, Combination
Endothelium, Vascular--drug effects
Enzyme Inhibitors--pharmacology
Female
Forearm--blood supply
Granulomatosis with Polyangiitis--blood
Humans
Immunosuppressive Agents--administration & dosage
Infliximab
Interleukin-6--blood
Male
Middle Aged
Mycophenolic Acid--administration & dosage
Nitric Oxide--blood
Nitric Oxide Synthase--antagonists & inhibitors
Nitric Oxide Synthase Type III
Pilot Projects
Plethysmography
Prednisolone--administration & dosage
Regional Blood Flow--drug effects
Tumor Necrosis Factor-alpha--analysis
Vasculitis--blood
omega-N-Methylarginine--pharmacology